2006
01 / AmoyDx Founded
01 / ISO13485
02 / GMP
01 / AmoyDx EGFR, KRAS, BRAF Kits are approved by NMPA and obtain CE certification.
02 / Cooperate with AstraZeneka.
01 / ADx-ARMS® obtain patent certificate.
01 / AmoyDx Medical Institute Founded.
02 / AmoyDx ROS1 Fusion Test Kit become a companion diagnostics for Pfizer's Crizotinib.
03 / DNA & RNA Extraction Kits.
01 / EML4-ALK, PIK3CA Kit are approved by NMPA and obtain CE certification.
02 / EGFR Kit is approved by NMPA for the detection of ctDNA from blood.
01 / AmoyDx ROS1, ALK/ROS1 Kits are approved by NMPA and obtain CE certification.
02 / AmoyDx Medical Institute obtain the Practice License of Medical Institution.
01 / Obtain the Medical Device Business License.
02 / EMQN Report: AmoyDx is the top 1 widely used kits and the top accurancy with more than 99%.
03 / NRAS, KN, KNB, KNBP Kits are approved by NMPA and obtain CE certification.
04 / Cooperate with Pfizer.
01 / EMQN Report: AmoyDx remain the top 1 widely used kits and the top accurancy.
02 / EGFR/ALK/ROS1 Kit is approved by NMPA and obtain CE certification.
03 / Cooperate with Merck.
01 / AmoyDx ROS1 Kit is approved by Japanese authority as companion diagnostics for Pfizer's Crizotinib.
02 / EMQN Report: AmoyDx remain the top 1 widely used kits and the top accurancy.
03 / Cooperate with Boehringer Ingelheim.
04 / AmoyDx starts IPO on Shenzhen Stock Exchange.
01 / NMPA grants liquid biopsy approval to AmoyDx Super-ARMS EGFR Mutation test.
02 / AmoyDx gets NMPA approval for Multi-Gene Mutations Detection Kit.
03 / AmoyDx Medical Institute receive accreditation from CAP.
04 / AmoyDx ROS1 Kit is approved by South Korea's MFDS as a companion diagnostics for Pfizer's Crizotinib.
05 / AmoyDx
Essential NGS panel got approval from Chinese authority.
06 / AmoyDx ROS1 Kit Got Approval in Taiwan.